Willingness of dialysis patients to participate in a randomized controlled trial of daily dialysis

Kidney International

Volumn 65, Issue 3, 2004, Pages 990-998

  Israni, Ajay K ^a   Halpern, Scott D ^b   McFadden, Christopher ^b   Israni, Rubeen K ^b   Wasserstein, Alan ^b   Kobrin, Sidney ^b   Berns, Jeffrey S ^b  

^a Center for Clinical Epidemiology and Biostatistics   (United States)

^b NONE

Author keywords

Daily dialysis; Randomized controlled clinical trials; Willingness to participate

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INTERVIEW; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MOTIVATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

EID: 1342322646     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00460.x     Document Type: Article

References (29)

1. DEPNER T: Why daily hemodialysis is better: Solute kinetics. Semin Dial 12:462-471, 1999
2. RPA/ASN POSITION ON DAILY DIALYSIS: Task Force on Daily Dialysis, Bethesda, MD, National Institutes of Health, NIDDK, 2001
3. WOODS J, PORT F, ORZOL S, et al: Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int 55:2467-2476, 1999
4. TRAEGER J, SIBAI-GALLAND R, DELAWARI E, et al: Daily versus standard hemodialysis: One year experience. Artif Organs 22:558-563, 1998
5. TING G: Future role of short daily hemodialysis, an opinion based on a California study. Nephrol Dial Transplant 12:448-450, 1999
6. BUONCRISTIANI U, QUNITALIANI G, COZZARI M, et al: Daily dialysis: Long-term clinical metabolic results. Kidney Int 33 (Suppl 24):S137-S140, 1988
7. BUONCRISTIANI U: Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 13:S148-S151, 1998
8. MOHR P, NEUMANN P, FRANCO S, et al: The case for daily dialysis: Its impact on costs and quality of life. Am J Kidney Dis 37:777-789, 2001
9. UNITED STATES RENAL DATA SYSTEM: USRDS Annual Data Report, Bethesda, MD, National Institutes of Health, NIDDK, 2002
10. ANONYMOUS: NIH seeking applications. Nephrol News Issues February:30-31, 2003
11. NATIONAL INSTITUTE OF DIABETES DIGESTIVE AND KIDNEY DISEASES (NIDDK): RFA DK-03-005, in Frequent Hemodialysis Clinical Trials, Bethesda, National Institutes of Health, 2002
12. HALPERN SD, KARLAWISH JHT, BERLIN JA: The continuing unethical conduct of underpowered clinical trials. JAMA 288:358-362, 2002
13. HALPERN S: Prospective preference assessment: A method to enhance the ethics and efficiency of randomized controlled trials. Controlled Clinical Trials 23:274-288, 2002
14. LOVATO LC, HILL K, HERTERT S, et al: Recruitment for controlled clinical trials: Literature summary and annotated bibliography. Controlled Clinical Trials 18:328-352, 1997
15. HUNNINGSHAKE DB, DARBY CA, PROBSTFIELD JL: Recruitment experience in clinical trials: Literature summary and annotated bibliography. Controlled Clinical Trials 8:6S-30S, 1987
16. Ross S, GRANT A, COUNSELL C, et al: Barriers to participation in randomised controlled trials: A systematic review. J Clin Epidemiol 52:1143-1156, 1999
17. SILVERMAN WA, ALTMAN DG: Patients'preferences and randomised trials. Lancet 347:171-174, 1996
18. FEINSTEIN AR: An additional basic science for clinical medicine. II. The limitations of randomized trials. Ann Intern Med 99:544-550, 1983
19. GREENE T: Trial design issues - Outcome and sample size, in Task Force on Daily Dialysis, Bethesda, MD, National Institutes of Health, NIDDK, 2001, pp 31-32
20. ANDRE M, REMBOLD S, PEREIRA C, et al: Prospective evaluation of an in-center daily dialysis hemodialysis program: Results of two years of treatment. Am J Nephrol 22:473-479, 2002
21. GALLAND R, TRAEGER J, ARKOUCHE W, et al: Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int 60:1555-1560, 2001
22. MOHR P: The economics of daily dialysis. Adv Renal Replace Ther 8:273-279, 2001
23. HALPERN S, METZGER D, BERLIN J, et al. Who will enroll? Predicting participation in a phase II AIDS vaccine trial. J Acquir Immune Defic Syndr 27:281-288, 2001
24. CASSILETH BR, LUSK EJ, MILLER DS, et al: Attitudes toward clinical trials among patients and the public. JAMA 248:968-970, 1982
25. HALPERN SD, KARLAWISH JHT, CASARETT D, et al. Hypertensive patients' willingness to participate in placebo-controlled trials: Implications for recruitment efficiency. Am Heart J (in press)
26. ROBERSON NL: Clinical trial participation: Viewpoints from racial/ethnic groups. Cancer 74:2687-2691, 1994
27. SUGARMAN J, KASS NE, GOODMAN SN, et al: What patients say about medical research. IRB: A Review of Human Subjects Research 20:1-7, 1998
28. Ross MW, JEFFORDS K, GOLD J: Reasons for entry into and understanding of HIV/AIDS clinical trials: a preliminary study. AIDS Care 6:77-82, 1993
29. KOBLIN BA, AVRETT S, TAYLOR PE, et al: Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE. J Acquir Immune Defic Syndr Hum Retrovirol 15:165-171, 1997